Logo image of CRRX.CA

CARERX CORP (CRRX.CA) Stock Fundamental Analysis

TSX:CRRX - Toronto Stock Exchange - CA14173C1059 - Common Stock - Currency: CAD

2.76  -0.04 (-1.43%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CRRX. CRRX was compared to 18 industry peers in the Consumer Staples Distribution & Retail industry. CRRX has a bad profitability rating. Also its financial health evaluation is rather negative. CRRX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRRX had negative earnings in the past year.
In the past year CRRX had a positive cash flow from operations.
CRRX had negative earnings in each of the past 5 years.
In the past 5 years CRRX always reported a positive cash flow from operatings.
CRRX.CA Yearly Net Income VS EBIT VS OCF VS FCFCRRX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

The Return On Assets of CRRX (-2.01%) is worse than 83.33% of its industry peers.
CRRX has a Return On Equity of -5.34%. This is amonst the worse of the industry: CRRX underperforms 83.33% of its industry peers.
CRRX's Return On Invested Capital of 3.34% is on the low side compared to the rest of the industry. CRRX is outperformed by 72.22% of its industry peers.
CRRX had an Average Return On Invested Capital over the past 3 years of 3.05%. This is significantly below the industry average of 8.33%.
The last Return On Invested Capital (3.34%) for CRRX is above the 3 year average (3.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.01%
ROE -5.34%
ROIC 3.34%
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
CRRX.CA Yearly ROA, ROE, ROICCRRX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

CRRX has a worse Operating Margin (2.03%) than 66.67% of its industry peers.
In the last couple of years the Operating Margin of CRRX has grown nicely.
CRRX has a Gross Margin of 29.47%. This is comparable to the rest of the industry: CRRX outperforms 50.00% of its industry peers.
CRRX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.03%
PM (TTM) N/A
GM 29.47%
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
CRRX.CA Yearly Profit, Operating, Gross MarginsCRRX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRRX is destroying value.
CRRX has more shares outstanding than it did 1 year ago.
CRRX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRRX has an improved debt to assets ratio.
CRRX.CA Yearly Shares OutstandingCRRX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRRX.CA Yearly Total Debt VS Total AssetsCRRX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.71, we must say that CRRX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CRRX (0.71) is worse than 88.89% of its industry peers.
CRRX has a debt to FCF ratio of 2.77. This is a good value and a sign of high solvency as CRRX would need 2.77 years to pay back of all of its debts.
CRRX's Debt to FCF ratio of 2.77 is amongst the best of the industry. CRRX outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.88 indicates that CRRX is somewhat dependend on debt financing.
CRRX's Debt to Equity ratio of 0.88 is fine compared to the rest of the industry. CRRX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 2.77
Altman-Z 0.71
ROIC/WACC0.5
WACC6.63%
CRRX.CA Yearly LT Debt VS Equity VS FCFCRRX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

CRRX has a Current Ratio of 0.99. This is a bad value and indicates that CRRX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CRRX (0.99) is worse than 72.22% of its industry peers.
CRRX has a Quick Ratio of 0.99. This is a bad value and indicates that CRRX is not financially healthy enough and could expect problems in meeting its short term obligations.
CRRX's Quick ratio of 0.71 is on the low side compared to the rest of the industry. CRRX is outperformed by 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.71
CRRX.CA Yearly Current Assets VS Current LiabilitesCRRX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

CRRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.22%, which is quite impressive.
CRRX shows a decrease in Revenue. In the last year, the revenue decreased by -1.09%.
Measured over the past years, CRRX shows a very strong growth in Revenue. The Revenue has been growing by 24.10% on average per year.
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%1.19%

3.2 Future

Based on estimates for the next years, CRRX will show a very strong growth in Earnings Per Share. The EPS will grow by 31.92% on average per year.
The Revenue is expected to grow by 2.70% on average over the next years.
EPS Next Y245.13%
EPS Next 2Y117.2%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue Next Year2.72%
Revenue Next 2Y3.99%
Revenue Next 3Y2.7%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRRX.CA Yearly Revenue VS EstimatesCRRX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
CRRX.CA Yearly EPS VS EstimatesCRRX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRRX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 27.17, the valuation of CRRX can be described as expensive.
66.67% of the companies in the same industry are cheaper than CRRX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CRRX to the average of the S&P500 Index (20.86), we can say CRRX is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 27.17
CRRX.CA Price Earnings VS Forward Price EarningsCRRX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRRX is valued a bit more expensive than 66.67% of the companies in the same industry.
CRRX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CRRX is cheaper than 61.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.8
EV/EBITDA 9.35
CRRX.CA Per share dataCRRX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CRRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRRX's earnings are expected to grow with 31.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.2%
EPS Next 3Y31.92%

0

5. Dividend

5.1 Amount

No dividends for CRRX!.
Industry RankSector Rank
Dividend Yield N/A

CARERX CORP

TSX:CRRX (5/2/2025, 7:00:00 PM)

2.76

-0.04 (-1.43%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-05 2025-03-05/bmo
Earnings (Next)05-07 2025-05-07
Inst Owners27.54%
Inst Owner ChangeN/A
Ins Owners10.16%
Ins Owner ChangeN/A
Market Cap173.16M
Analysts80
Price Target3.73 (35.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-277.53%
Min EPS beat(2)-296.08%
Max EPS beat(2)-258.98%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.26%
Min Revenue beat(2)-2.13%
Max Revenue beat(2)-0.38%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-2.34%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)4
Avg Revenue beat(16)-1.04%
PT rev (1m)7.34%
PT rev (3m)5.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-62.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-41.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.8%
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.17
P/S 0.47
P/FCF 5.8
P/OCF 4.56
P/B 2.06
P/tB N/A
EV/EBITDA 9.35
EPS(TTM)-0.07
EYN/A
EPS(NY)0.1
Fwd EY3.68%
FCF(TTM)0.48
FCFY17.25%
OCF(TTM)0.61
OCFY21.94%
SpS5.84
BVpS1.34
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.01%
ROE -5.34%
ROCE 4.64%
ROIC 3.34%
ROICexc 3.54%
ROICexgc 11.34%
OM 2.03%
PM (TTM) N/A
GM 29.47%
FCFM 8.15%
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)11.1%
ROICexgc(5y)N/A
ROCE(3y)4.24%
ROCE(5y)N/A
ROICexcg growth 3Y15.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.67%
ROICexc growth 5YN/A
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 2.77
Debt/EBITDA 2.8
Cap/Depr 42.28%
Cap/Sales 2.21%
Interest Coverage 1.28
Cash Conversion 142.58%
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.71
Altman-Z 0.71
F-Score7
WACC6.63%
ROIC/WACC0.5
Cap/Depr(3y)51.22%
Cap/Depr(5y)43.4%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y245.13%
EPS Next 2Y117.2%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%1.19%
Revenue Next Year2.72%
Revenue Next 2Y3.99%
Revenue Next 3Y2.7%
Revenue Next 5YN/A
EBIT growth 1Y3.17%
EBIT growth 3Y15.72%
EBIT growth 5YN/A
EBIT Next Year369.51%
EBIT Next 3Y66.29%
EBIT Next 5YN/A
FCF growth 1Y59.94%
FCF growth 3Y480.16%
FCF growth 5Y59.88%
OCF growth 1Y38.78%
OCF growth 3Y73.54%
OCF growth 5Y42.97%